Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of LEE011 in Asian patients with advanced solid tumors
jRCT2080222122Phase 1
- Sponsor
- Novartis
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ribociclib in Nonhematologic neoplasms, sponsored by Novartis.
02
Drugs
ribociclib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080222122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222122.